NCT02824380View on ClinicalTrials.gov

Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Androgenic Alopecia

Interventions

DRUG

DA-4001 H

5% minoxidil / high dose of finasteride

DRUG

DA-4001 L

5% minoxidil / low dose of finasteride

Trial Locations (1)

Unknown

Inje University Busan Paik Hospital, Busan

All Listed Sponsors

lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02824380 - Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia | Biotech Hunter | Biotech Hunter